{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895236935680.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1606468"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1606468"}}],"dc:title":[{"@value":"Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895236935811","@type":"Researcher","foaf:name":[{"@value":"Xavier Montalban"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935683","@type":"Researcher","foaf:name":[{"@value":"Stephen L. Hauser"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935815","@type":"Researcher","foaf:name":[{"@value":"Ludwig Kappos"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935684","@type":"Researcher","foaf:name":[{"@value":"Douglas L. Arnold"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935810","@type":"Researcher","foaf:name":[{"@value":"Amit Bar-Or"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935690","@type":"Researcher","foaf:name":[{"@value":"Giancarlo Comi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935685","@type":"Researcher","foaf:name":[{"@value":"Jérôme de Seze"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935689","@type":"Researcher","foaf:name":[{"@value":"Gavin Giovannoni"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935816","@type":"Researcher","foaf:name":[{"@value":"Hans-Peter Hartung"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935681","@type":"Researcher","foaf:name":[{"@value":"Bernhard Hemmer"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935817","@type":"Researcher","foaf:name":[{"@value":"Fred Lublin"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935813","@type":"Researcher","foaf:name":[{"@value":"Kottil W. Rammohan"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935808","@type":"Researcher","foaf:name":[{"@value":"Krzysztof Selmaj"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935691","@type":"Researcher","foaf:name":[{"@value":"Anthony Traboulsee"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935680","@type":"Researcher","foaf:name":[{"@value":"Annette Sauter"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935812","@type":"Researcher","foaf:name":[{"@value":"Donna Masterman"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935814","@type":"Researcher","foaf:name":[{"@value":"Paulo Fontoura"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935688","@type":"Researcher","foaf:name":[{"@value":"Shibeshih Belachew"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935687","@type":"Researcher","foaf:name":[{"@value":"Hideki Garren"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935809","@type":"Researcher","foaf:name":[{"@value":"Nicole Mairon"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935686","@type":"Researcher","foaf:name":[{"@value":"Peter Chin"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895236935682","@type":"Researcher","foaf:name":[{"@value":"Jerry S. Wolinsky"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2017-01-19","prism:volume":"376","prism:number":"3","prism:startingPage":"209","prism:endingPage":"220"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1606468"}],"createdAt":"2016-12-21","modifiedAt":"2023-08-21","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360013168762426240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282425573760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Multiple sclerosis: Possibility of a gut environment-induced disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865744811264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905624232832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Senescence-associated T cells in immunosenescence and diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658392683136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849942085383040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849946819041792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567424830336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045261154816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412892426168192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390014104843265024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of primary progressive multiple sclerosis with improvement in cognitive impairment by anti-CD20 monoclonal antibody therapy"},{"@language":"ja","@value":"抗CD20モノクローナル抗体治療により高次脳機能障害が改善した一次性進行型多発性硬化症の1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390293025962989056","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"I. Multiple Sclerosis"},{"@language":"ja","@value":"I．多発性硬化症"}]},{"@id":"https://cir.nii.ac.jp/crid/1390568772520931328","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"5) The Cutting Edge of Pathomechanism and Therapy for Intractable Neuroimmunological Diseases"},{"@language":"ja","@value":"5）難治性神経免疫疾患の病態と治療の最前線"},{"@value":"難治性神経免疫疾患の病態と治療の最前線"},{"@language":"ja-Kana","@value":"ナンチセイ シンケイ メンエキ シッカン ノ ビョウタイ ト チリョウ ノ サイゼンセン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390587196511235584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"病理学的に急性炎症性病変や再髄鞘化所見がめだたなかった全経過11年の一次性進行型多発性硬化症の1剖検例"},{"@language":"en","@value":"An autopsy case of primary progressive multiple sclerosis with minimal acute inflammation and remyelination over an 11-year course"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1606468"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2021.103407_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1073/pnas.1906438116_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1016/j.neuint.2019.104475_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.2169/naika.109.1764_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1073/pnas.2207291120_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1093/intimm/dxae056_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.2169/naika.110.1562_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-002092_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1038/s41419-018-1118-4_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1186/s12974-019-1574-5_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2020.102251_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001779_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1016/s0140-6736(19)31817-3_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"},{"@type":"CROSSREF","@value":"10.1016/j.neuint.2018.11.023_references_DOI_BzxU9fqXfFIbkh0bayaEDxXlBRf"}]}